We present an elderly gentleman with unilateral critical limb ischemia secondary to a long segment occlusion of the ipsilateral common and external iliac arteries. An endovascular revascularisation procedure was required as the clinical background made him a poor candidate for a major surgery. A special stent with high tensile strength and axial flexibility was chosen for this purpose and was deployed with its distal end at the hip joint for optimal positioning. In the post-procedural period, good blood flow was demonstrable through the stent even on flexion of the hip. The restoration of blood flow to the limb contributed significantly to the healing of a post-operative wound on his foot.
Learning objectives 1. Describe why, when, with whom, and where to use a vena cava filter
2. Discuss why imaging the vena cava is important 3. Compare and contrast “tried and true” vs state-of-the-art technology
4. Utilize appropriate techniques for placing and retrieving filters 5.Avoid complications in the use of vena cava filters.
6. Explore ways to build successful referral patterns.
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiology, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
This activity has been developed for Physicians, Pharmacists, Nurses, and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
This activity has been developed for Physicians, Pharmacists, Nurses, and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
Presented By: Tony Das, MD, Director of Peripheral Interventions, Presbyterian Hospital
ARTICLES
NEWS
Editor's Corner: Retrievable IVC Filters: Advance or Gimmick? Frank J. Criado, MD
The article by Arko et al served as the foundation for this editorial. The paper describes a first-in-man clinical experience (10 patients) with a new retrievable vena cava filter (VCF). The design of the Crux IVCF appears unique and quite interesting. Instead of the more standard conical, strut-and-hook designs we have all seen many times in the past, this new device features a symmetrical double-loop helical construct.
Case Study: Unusual Life-Threatening Complications of a Ruptured Infrarenal Aortic Aneurysm in a Young Adult
Kumaran Chinnappan, MD, 1Archana Abhyankar, MD, Zafar Jameel, MD, John Cosgrove, MD
A 34-year-old man presented with a ruptured infrarenal aortic aneurysm for which he underwent emergency repair with a tube Dacron tube graft. During the subsequent three years, he developed multiple suture-line false aneurysms with disruptions requiring repair with Dacron, Gortex, and superficial femoral veins. He eventually required ligation of the infrarenal aorta, followed by bilateral Gortex axillobifemoral grafts. We present the unusual life-threatening complications and management of an abdominal aortic aneurysm in a young adult with unidentified etiology.
Case Study and Review:
Giant Splenic Artery Aneurysm Muhammad Asad, MD, FRCS, Mahalingam Sivakumar, MD, FRCS, FACS
Splenic artery aneurysms (SAA) are being identified with increasing frequency as a result of the more liberal use of diagnostic imaging, particularly computed tomography scans. A large variety of causes may lead to the formations of SAA, and among them pancreatitis is one of the more frequent. The majority of SAA are asymptomatic. Symptoms usually occur due to their complications. Early diagnosis is important because of the high mortality rate associated with rupture of the large SAA. We report a case of a 5 cm SAA in a patient with multiple severe comorbid conditions, who at the time of diagnosis had acute pancreatitis.
Terumo Partners with GHX for More Efficient Electronic Ordering Capabilities
SOMERSET, NJ – Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation (TMC), announces a new partnership between TMC and Global Health Exchange (GHX); expanding its reputation for supplying technologically advanced quality to supply chain management.
Working with GHX and its Electronic Data Interchange (EDI) system, Terumo Interventional Systems is looking to deliver providers what they want—when they want it. Through this e-commerce platform’s unique, streamlined process, hospitals are now easily able to place orders, generate receipts, and change and track orders with Terumo.
ANGIODYNAMICS ANNOUNCES PLAN TO LAUNCH
NEVERTOUCH™ VENACURE® PRODUCT LINE
QUEENSBURY, N.Y. (April 2, 2007) – AngioDynamics, Inc. (NASDAQ: ANGO) announced today plans to launch the NeverTouch VenaCure procedure kit for laser treatment of severe varicose veins. The improved VenaCure design will employ a proprietary laser fiber technology designed to provide an enhanced level of perforation protection by further preventing contact between the fiber tip and the vessel wall during treatment.
Press Release: Targeted Renal Therapy for Patients at Risk for Contrast-Induced NephropathyMulticenter Registry Results Presented at Society of Interventional Radiology Meeting
Data from a multicenter registry of targeted renal therapy (TRT™) in patients at high risk for contrast-induced nephropathy (CIN) – a significant cause of kidney failure and a large unmet market need
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
Cook Medical’s ZILVER PTX Paclitaxel-Eluting Stent (DES) trial results demonstrated no stent fractures. The major adverse event (MAE) rate was equivalent to conventional balloon angioplasty treatment at its six-month follow-up point, as reported by the trial’s national principal investigator.
This activity is designed for Invasive Cardiologists, Vascular Surgeons, Interventional Neurologists, Interventional Radiologists, Nurses and Technologists.
Topics include direct thrombin inhibition, use of direct thrombin inhibitors during PPI, and adjunctive pharmacology during carotid artery stenting.
Dr. Zvonimir Krajcer is a Clinical Professor of Medicine at Baylor College of Medicine and at the University of Texas Health Science Center in Houston. Dr. Krajcer has pioneered a technique of non-surgical repair of abdominal aortic aneurysms with stent grafts. His special area of interest is non-surgical treatment of peripheral vascular disease with stents and stent grafts.
SPECIAL SUPPLEMENT: 
Complimentary Accredited Booklet and CD-Rom
Using Advanced Technology to
Treat Occluded Below-the-Knee Arteries
Superior Mesenteric Artery Revascularization and
Retrograde Visualization
